About the Authors
- Ke Ren
-
Contributed equally to this work with: Ke Ren, Wei Zhang
Affiliations Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, China, Jiangsu Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, China
- Wei Zhang
-
Contributed equally to this work with: Ke Ren, Wei Zhang
Affiliations Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, China, Jiangsu Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, China
- Xiaoqing Chen
-
Affiliation The Hoffmann Institute of Immunology, Guangzhou Medical University, Guangzhou, China
- Yingyu Ma
-
Affiliations Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, China, Jiangsu Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, China
- Yue Dai
-
Affiliation Jiangsu Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, China
- Yimei Fan
-
Affiliation Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, China
- Yayi Hou
-
Affiliation Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, China
- Ren Xiang Tan
-
* E-mail: erguang@nju.edu.cn; rxtan@nju.edu.cn
Affiliations Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, China, Jiangsu Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, China, Nanjing University of Chinese Medicine, Nanjing, China
- Erguang Li
-
* E-mail: erguang@nju.edu.cn; rxtan@nju.edu.cn
Affiliations Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, China, Jiangsu Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, China
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceptualization: EL KR RXT. Formal analysis: EL KR XC. Funding acquisition: EL RXT. Investigation: KR WZ. Methodology: EL KR WZ XC YM. Resources: YH RXT. Software: YF. Supervision: EL. Validation: KR XC YD. Visualization: KR WZ. Writing – original draft: KR EL. Writing – review & editing: EL KR.